Skip to main content

Month: September 2021

Yamana Gold Reports Positive Initial Exploration Drill Results at Wasamac; Provides an Update on Its Generative Exploration Program, Which Continues to Show Significant Progress of Both Advanced and Early Stage Exploration Projects

Figure 1Project Location Map.Figure 2Wasamac Project, Plan Map of Wildcat Target Area Showing 2021 Drilling Highlights.Figure 3Wasamac Project, Oblique Longitudinal and Cross Section Views of the Wildcat Target Area Showing Historical and 2021 Drilling Highlights.Figure 4Lavra Velha Plan Map Showing Geology, Lavra Velha and Lavra Velha SW Deposits, and 2021 Drilling Highlights, as Discussed in Text.Figure 5Plan Map of Key Regional Geology Features, Main Targets and Surface Rock Gold Geochemistry, Lavra Velha and Matinos Districts.Figure 6Borborema Project, São Francisco Sector Details, District Targets and Geology.Figure 7Jacobina Norte Project Plan Map Showing Main Target Areas, Rock Gold Geochemistry and Drilling.Figure...

Continue reading

JLT Mobile Computers AB plans to strengthen its presence in the French market

JLT Mobile Computers AB plans to strengthen its presence in the French market Letter-of-intent signed to acquire ID Work, JLT’s largest French sales partner, with plans to open own sales office in France Växjö, Sweden, September 13, 2021 * * * JLT Mobile Computers, a leading supplier of reliable computers for demanding environments, today announced that it is in continuous negotiations and has signed a letter-of-intent with its French authorized sales partner ID Work, with the aim of acquiring their operations and establishing a sales office under the JLT brand in the French market. A cornerstone of JLT’s growth strategy is a strong sales channel consisting of both internal staff and a network of authorized sales partners. Since its start in 2013, the entrepreneur who founded ID Work has successfully built-up sales in France through...

Continue reading

Boehringer Ingelheim and OSE Immunotherapeutics to Present Phase 1 Results with First-in-Class SIRPα Inhibitor BI 765063 in Advanced Solid Tumors at ESMO 2021

BI 765063, a first-in-class SIRPα inhibitor in the SIRPα/CD47 “Don’t eat me” pathway, is being developed under collaborative agreement between OSE Immunotherapeutics and Boehringer Ingelheim.NANTES, France, Sept. 13, 2021 (GLOBE NEWSWIRE) — OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) today announced that promising data from dose escalation Phase 1 of selective SIRPα inhibitor BI 765063 in patients with advanced solid tumors (ePoster 983P) will be presented(1) at the 2021 European Society for Medical Oncology (ESMO) Virtual Conference to be held on September 16 – 21, 2021. This Phase 1 clinical trial aims to evaluate the safety and efficacy of BI 765063 as monotherapy and in combination with ezabenlimab (BI 754091; anti-PD-1 mAb) in patients with advanced solid tumors. The dose escalation part (Step 1) of the Phase...

Continue reading

Arcadis energy transition report: radical transformation of energy sector needed to reach net zero in time to prevent major global warming threshold

Energy sector must lead the change by rapidly decarbonizing and increasing its capacity To reach net zero and limit warming to 1.5 degrees, the global energy sector needs to halve emissions this decade €6 trillion – approximately 7% of global GDP – in investments will be required to realize this ambitious transition Investments would lead to net benefits to society and the economy Average consumer energy bills will drop if transition is done rightAmsterdam, September 13, 2021 – Arcadis (EURONEXT: ARCAD), the leading global design & consultancy organization for natural and built assets, published today a new research report called “Supercharging Net Zero”, which uses economic modeling to examine how the international energy sector can lead the way to achieving net zero greenhouse emissions. The report confirms that, if the global...

Continue reading

Valneva Receives Notice of Termination of COVID-19 Vaccine Supply Agreement by UK Government

Saint-Herblain (France), September 13, 2021 – Valneva SE, a specialty vaccine company, today announced that it has received a termination notice from the UK Government (“HMG”) in relation to the Supply Agreement for its COVID-19 vaccine candidate, VLA2001. The contract provides HMG with the right to terminate. HMG has alleged that the Company is in breach of its obligations under the Supply Agreement, but the Company strenuously denies this. Valneva is continuing its VLA2001 development plan. Testing for the Company’s pivotal Phase 3 trial, Cov-Compare, is ongoing at Public Health England (“PHE”). Valneva recently announced that its Phase 3 results are expected to be available early in the fourth quarter and that these results will form part of its rolling submission for conditional approval of VLA2001 with the UK’s Medicines and Healthcare...

Continue reading

Innovative Payment Solutions, Inc. Announces Participation at the H.C. Wainwright 23rd Annual Global Investment Conference September 13-15, 2021 (Virtual Conference)

CARMEL, Calif., Sept. 12, 2021 (GLOBE NEWSWIRE) — Innovative Payment Solutions, Inc (OTCQB:IPSI) (“Innovative” or the “Company”), today announced it will be featured as a presenting company at the H.C. Wainwright 23rd Annual Global Investment Virtual Conference.  The conference is being held as a virtual conference on September 13-15, 2021. William Corbett, CEO of Innovative, will provide an overview of the Company’s business during the presentation.   If you are an institutional or retail investor, and would like to listen to the Company’s presentation, please click on the following link (www.hcwevents.com/annualconference) to register for the conference. You may also listen to the company presentation online at: https://journey.ct.events/view/15da3e52-9d12-4c59-acac-7cad734093ce, starting on September 13 at 7:00 am EST...

Continue reading

Dolby and Multi-Platinum Singer-Songwriter Olivia Rodrigo Team Up to Share an Intimate Look at Her Hit Song “Traitor”

Fans can enjoy Olivia’s debut studio album SOUR in Dolby Atmos on Apple Music todayOlivia Rodrigo X Dolby AtmosFans can enjoy Olivia’s debut studio album SOUR in Dolby Atmos on Apple Music todayDolby teamed up with multi-platinum singer-songwriter Olivia Rodrigo to celebrate a new era for music in Dolby Atmos.SAN FRANCISCO, Sept. 12, 2021 (GLOBE NEWSWIRE) — Dolby Laboratories, Inc. (NYSE: DLB), a leader in immersive entertainment experiences, teamed up with multi-platinum singer-songwriter Olivia Rodrigo to celebrate a new era for music in Dolby Atmos, which is transforming how music is created and enjoyed. Fans looking to connect with Olivia on a deeper, more emotional level can enjoy SOUR today in Dolby Atmos on Apple Music. “I create music to tell my story and to share how I’m...

Continue reading

Dolby and Justin Bieber Team Up to Go Inside the Story of his Latest Single “Ghost”

Fans can enjoy “Ghost” and his latest multi-platinum album JUSTICE today in Dolby Atmos on Apple MusicDolby Atmos X Justin BieberFans can enjoy “Ghost” and Justin Bieber’s latest multi-platinum album JUSTICE today in Dolby Atmos on Apple MusicDolby teamed up with global superstar Justin Bieber to celebrate his latest single “Ghost” and a new era for music in Dolby Atmos.SAN FRANCISCO, Sept. 12, 2021 (GLOBE NEWSWIRE) — Dolby Laboratories, Inc. (NYSE: DLB), a leader in immersive entertainment experiences, teamed up with global superstar Justin Bieber to celebrate his latest single “Ghost” and a new era for music in Dolby Atmos, which is transforming how music is created and enjoyed. In this long-form commercial, the world will see the versatility of Justin’s musical talent while exploring...

Continue reading

Dolby Teams up with The Weeknd to Explore How He Creates Worlds with Music

Fans can enjoy The Weeknd’s Latest Single “Take My Breath” in Dolby Atmos on Apple MusicThe Weeknd X Dolby AtmosFans can enjoy The Weeknd’s Latest Single “Take My Breath” in Dolby Atmos on Apple Music.Dolby teamed up with The Weeknd to celebrate a new era for music in Dolby Atmos, which is transforming how music is created and enjoyed.SAN FRANCISCO, Sept. 12, 2021 (GLOBE NEWSWIRE) — Dolby Laboratories, Inc. (NYSE: DLB), a leader in immersive entertainment experiences, teamed up with The Weeknd to celebrate a new era for music in Dolby Atmos, which is transforming how music is created and enjoyed. The long-form commercial explores how The Weeknd creates sensory experiences through music. Fans looking to connect with The Weeknd on a deeper, more emotional level, can experience his recently released...

Continue reading

MacroGenics Announces Presentations at ESMO 2021 Virtual Annual Congress

ROCKVILLE, MD, Sept. 12, 2021 (GLOBE NEWSWIRE) — MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer, today announced poster presentations relating to multiple investigational product candidates at the European Society for Medical Oncology (ESMO) Virtual Conference, taking place September 16-21, 2021. Posters will be available on September 16, 2021. Details are as follows: 620P – MGC018, an Anti-B7-H3 Antibody-Drug Conjugate (ADC), in Patients with Advanced Solid Tumors: Preliminary Results of Phase 1 Cohort Expansion Preliminary clinical results from the Phase 1 cohort expansion study of MGC018 in patients with metastatic castration-resistant prostate cancer and non-small cell lung cancer will...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.